Related Experiment Videos
What can DNA rearrangements tell us about solid hematolymphoid neoplasms?
1Department of Pathology, Stanford University, California.
The American Journal of Surgical Pathology
|January 1, 1990
Summary
DNA rearrangements in antigen receptor genes serve as clonal molecular markers for diagnosing lymphoid neoplasms. These markers, detected via Southern blot or PCR, aid classification when other methods are ambiguous, despite current limitations.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- DNA rearrangements in antigen receptor genes and chromosomal translocations are crucial in lymphoid tissue analysis.
- These rearrangements function as clonal molecular markers, detectable through techniques like Southern blot hybridization and polymerase chain reaction (PCR) amplification.
Purpose of the Study:
- To highlight the diagnostic impact of analyzing DNA rearrangements in lymphoid tissue biopsy specimens.
- To explore the utility of these molecular markers in diagnosing and subclassifying lymphoid neoplasms, especially in ambiguous cases.
Main Methods:
- Detection of DNA rearrangements using Southern blot hybridization.
- Detection of DNA rearrangements using polymerase chain reaction (PCR) amplification.
Main Results:
- DNA rearrangements provide reliable clonal molecular markers for lymphoid neoplasms.
- These markers are particularly valuable when morphologic or immunophenotypic findings are inconclusive.
Conclusions:
- DNA rearrangement analysis significantly impacts the diagnostic evaluation of lymphoid tissues.
- While effective, current methods have limitations that ongoing research aims to address.